Overview

Dexmedetomidine Pharmacokinetics in the Obese

Status:
Completed
Trial end date:
2014-05-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to characterize, using two different modeling approaches, one based on purely statistic concept and one using a more mechanistic analysis, the influence of body weight and composition on the pharmacokinetic of dexmedetomidine.
Phase:
Phase 4
Details
Lead Sponsor:
Pontificia Universidad Catolica de Chile
Treatments:
Dexmedetomidine